Federal Government Must Prepare for Psychedelic Medicine Expansion, VA Official Says
The federal government needs to prepare for a new era of mental health treatment. Rachel Yehuda, mental health director at the VA’s James J. Peters Medical Center, told CBS Mornings that the nation must “gear up” to safely provide psychedelic medicines to veterans. The statement signals a significant shift in how the government views mental health care for those who served.
Looking for treatment? Find ketamine clinics closest to you as well as other psychedelic therapies in your area.
| Key Takeaway | Details |
|---|---|
| Government Preparedness | VA must develop infrastructure for safe psychedelic therapy delivery |
| Therapist Training | Medical professionals need specialized education on psychedelic facilitation |
| Treatment Approach | One to three supervised sessions lasting six to eight hours each |
| Substances in Focus | Psilocybin, MDMA, and ibogaine show promise for PTSD and trauma |
| Political Support | Bipartisan congressional backing and Trump administration interest |
| Safety Requirements | Professional supervision essential; unsupervised use poses risks |
New:Â Interested in Being Part of a Psychedelics-Focused Clinical Trial? Sign Up Here
A Different Path for Mental Health
Traditional mental health treatments focus on managing symptoms. Psychedelics offer something else entirely. These substances allow patients to access buried emotions, memories, and trauma during supervised therapeutic sessions. Yehuda emphasized that this approach targets the root causes rather than simply dampening discomfort.
The treatment model requires extensive preparation and support. Sessions with psilocybin or MDMA can last six to eight hours. Trained therapists remain present throughout the experience, helping patients process whatever emerges. The goal is lasting healing rather than ongoing medication management.
Yehuda made clear that unsupervised access to psychedelics carries risks. The substances themselves have low toxicity. However, the psychological material that surfaces can overwhelm unprepared individuals. Professional guidance helps patients integrate these experiences safely and productively.
Political Momentum Builds
Support for psychedelic therapy spans political divides. Representatives Lou Correa and Jack Bergman introduced legislation providing $30 million annually for VA centers of excellence focused on psychedelics research. HHS Secretary Kennedy committed to expanding access within 12 months. VA Secretary Doug Collins visited psychedelics research facilities and met with advocates.
Congress included language in recent spending bills encouraging VA to support psychedelics research. The agency already awarded $1.5 million to study MDMA assisted therapy for veterans with PTSD and alcohol use disorder. Even conservative media figures have praised psychedelic treatments, including a Navy SEAL veteran who credited the therapy with helping him process combat trauma.
The momentum represents decades of advocacy finally reaching decision makers. Veterans desperately need better mental health options. Psychedelic medicine may provide exactly that.
